Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc News Story

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547

BRIEF-Cellular Biomedicine Reports Q1 Loss Per Share Of $0.60

Wed 6th May, 2020 10:51pm
May 6 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP REPORTS Q1 2020 FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
    * CELLULAR BIOMEDICINE GROUP INC - QTRLY LOSS PER SHARE
$0.60

Source text for Eikon:  ID:nPnbRsFfha 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.